Is Advanced Enzyme Technologies a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Neeraj Pandey
- Category: Market
Advanced Enzyme Technologies share price around Rs 298. 28.9% below 52-week high of Rs 419. Q1 FY27 revenue Rs 203 crore, up 4.1% YoY. PAT Rs 39 crore, down 4.6%. PE 19x.
Quick Answer
Advanced Enzyme Technologies’ Q1 FY27 results were mixed, with revenue at Rs 203 crore but PAT falling 5% to Rs 39 crore. The Advanced Enzyme Technologies share price near Rs 298 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Advanced Enzyme Technologies is a good buy right now.
The Advanced Enzyme Technologies share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Advanced Enzyme Technologies is a manufacturer of industrial and specialty enzymes for pharma, food and other sectors, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.
Revenue for the quarter came in at Rs 203 crore, up 4.1% year on year, while profit after tax came in at Rs 39 crore, down 4.6% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Advanced Enzyme Technologies share price from here.
This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Advanced Enzyme Technologies share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.
Click Here – Get Free Investment Predictions
Advanced Enzyme Technologies Q1 FY27 Financial Highlights
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 203 crore | Rs 195 crore | 4.1% |
| EBITDA | Rs 64 crore | Rs 65 crore | -2.0% |
| Operating Margin | 33.7% | 35.1% | NA |
| Profit Before Tax | Rs 54 crore | Rs 55 crore | -2.5% |
| Net Profit / (Loss) | Rs 39 crore | Rs 40 crore | -4.6% |
Advanced Enzyme Technologies Q1 FY27 Performance Analysis
Check Advanced Enzyme Technologies Fundamentals on Univest Screener
Revenue growth of 4.1% for the quarter came from steady demand across the company’s core business, keeping the topline trend intact for the industrial and specialty enzymes manufacturing sector.
Profitability is where the quarter disappointed. PAT fell 5% year on year to Rs 39 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Advanced Enzyme Technologies share price this quarter.
On a sequential basis, revenue moved down 3.7% sequentially from Rs 211 crore in the March 2026 quarter and net profit moved down 14.7% sequentially from Rs 45 crore in the prior quarter, giving a fuller picture of the trend behind the Advanced Enzyme Technologies share price than the year on year comparison alone.
Key Business Factors in Q1 FY27
Revenue Trend
Advanced Enzyme Technologies’ revenue grew 4.1% year on year this quarter, taking the quarterly base to Rs 203 crore in an industrial and specialty enzymes manufacturing business that remains sensitive to demand and pricing cycles that ultimately feed through to the Advanced Enzyme Technologies share price.
Margin Movement
EBITDA fell to Rs 64 crore from Rs 65 crore, with operating margin slipping to 33.7% from 35.1%, pointing to cost or pricing pressure that management will need to manage through the rest of FY27.
Balance Sheet Position
Advanced Enzyme Technologies carries a low debt-to-equity ratio of 0.02, giving it a conservative balance sheet heading into the rest of FY27.
Valuation Context
The stock trades at a PE of 19.3x, below the industry average of 38.0x, which is worth factoring into any read of whether the Advanced Enzyme Technologies share price is expensive or reasonably priced.
Dividend Details
No interim dividend was declared alongside Advanced Enzyme Technologies’ Q1 FY27 results. The stock currently carries a trailing dividend yield of 1.81%, based on dividends paid over the last year. Investors tracking the Advanced Enzyme Technologies share price for income should watch the company’s announcements around its next annual results for any dividend decision.
Advanced Enzyme Technologies Share Price Outlook for FY27
The key question for the rest of FY27 is whether Advanced Enzyme Technologies can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Advanced Enzyme Technologies share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.
A stabilising or improving margin trend in the next result would be the clearest signal that this quarter’s profit decline was a temporary setback rather than the start of a longer slide for the Advanced Enzyme Technologies share price.
Advanced Enzyme Technologies Stock Performance
Download the Univest iOS App or Univest Android App to track Advanced Enzyme Technologies’ live share price and get daily stock updates.
The Advanced Enzyme Technologies share price was trading around Rs 298 as results season played out in late August 2026, roughly 28.9% below its 52-week high of Rs 419 and well above its 52-week low of Rs 252.
The Advanced Enzyme Technologies share price has likely already absorbed some of this quarter’s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off. On profitability ratios, the company reports a return on equity of 10.34% and a book value of around Rs 146 per share, both useful reference points when judging whether the current price is reasonable.
Key Risks
Profitability Risk
The quarter’s profit trend is the clearest risk here. Until Advanced Enzyme Technologies shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.
Sector and Demand Risk
As an industrial and specialty enzymes manufacturing business, Advanced Enzyme Technologies’ results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Advanced Enzyme Technologies share price well before the next result.
Execution Risk
Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.
Conclusion
Advanced Enzyme Technologies’ Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 5% to Rs 39 crore even as revenue rose. The Advanced Enzyme Technologies share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter’s numbers until the margin trend turns around.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Advanced Enzyme Technologies Q1 FY27 Results
What were Advanced Enzyme Technologies’ Q1 FY27 results?
Ans. Advanced Enzyme Technologies reported Q1 FY27 revenue of Rs 203 crore, up 4.1% year on year, and PAT of Rs 39 crore, down 4.6% year on year.
Is Advanced Enzyme Technologies a good buy after its Q1 FY27 results?
Ans. Advanced Enzyme Technologies’ profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.
What is the Advanced Enzyme Technologies share price today?
Ans. The Advanced Enzyme Technologies share price was trading around Rs 298 in late August 2026, about 28.9% below its 52-week high of Rs 419 and well above its 52-week low of Rs 252.
What is Advanced Enzyme Technologies’ revenue and profit for Q1 FY27?
Ans. Advanced Enzyme Technologies reported revenue of Rs 203 crore and a net profit of Rs 39 crore for the quarter ended June 30, 2026.
Did Advanced Enzyme Technologies declare a dividend with its Q1 FY27 results?
Ans. No interim dividend was declared alongside Advanced Enzyme Technologies’ Q1 FY27 results. Investors should track the company’s next annual results for any dividend announcement.
What is Advanced Enzyme Technologies’ PE ratio and is it expensive?
Ans. The Advanced Enzyme Technologies share price trades at a trailing PE of 19.3x, against an industry average of 38.0x. Investors should compare this with the company’s growth rate before judging value.
What are the key risks for Advanced Enzyme Technologies investors right now?
Ans. The quarter’s profit trend is the clearest risk here. Until Advanced Enzyme Technologies shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.
What is Advanced Enzyme Technologies’ promoter shareholding?
Ans. Promoter shareholding data for Advanced Enzyme Technologies was not fully available for this quarter and should be checked on the company’s official filings.
